This study suggests that lowering SBP <145 mmHg before oral anticoagulation initiation may decrease risk for hemorrhagic stroke in patients with hypertension and atrial fibrillation.
Researchers studied the effect of dapagliflozin on cumulative sodium excretion in patients with type 2 diabetes and preserved kidney function while sodium intake was being strictly controlled.
Nonpharmacologic therapy may improve management and the metabolic syndrome in patients with gout.
Researchers evaluated the association of metabolic and cardiovascular comorbidities in patients with gout receiving treat-to-target uric acid lowering therapy.
